• Medicare Part B reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 19/ S.3129, the Lower Costs, More Cures Act of 2019. International Pricing Index model (83 FR 54546). Supervision requirements in CMS-1744-IFC.
• Distribution changes in the private market.
• Inclusion of COBRA subsidy in coronavirus relief legislation.

Duration: July 17, 2019 to June 30, 2020

General Issues: Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

Spending: about $160,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2019: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)